Drug Profile
Research programme: GPR119 agonists - Bristol-Myers Squibb
Alternative Names: G-protein coupled receptor 119 agonists - Bristol-Myers SquibbLatest Information Update: 13 Nov 2013
Price :
$50
*
At a glance
- Originator Bristol-Myers Squibb
- Class
- Mechanism of Action GPR119 protein agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Diabetes mellitus; Metabolic disorders
Most Recent Events
- 07 Nov 2013 Discontinued for Diabetes mellitus in USA (unspecified route)
- 07 Nov 2013 Discontinued for Metabolic disorders in USA (unspecified route)
- 31 Dec 2009 Investigation in Diabetes mellitus in USA (unspecified route)